查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1542927

全球外鼻擴張器市場 - 2024-2031

Global External Nasal Dilator Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

2023年，全球外鼻擴張器市場達到1.798億美元，預計2031年將達到2.7322億美元，2024-2031年預測期間複合年成長率為5.5%。

外鼻擴張器 (END) 是包含中央鬆緊帶的黏合帶，可透過防止外側鼻前庭塌陷來減少鼻阻力和吸氣壓力。 END 水平塗抹於鼻背皮膚。

外鼻擴張器是塑膠或矽膠裝置。它是 2 條帶有彈簧狀帶的黏合劑，透過抬起並保持鼻子兩側打開來擴張鼻道。此動作可減少鼻氣道阻力並改善氣流。

由於打鼾、睡眠相關疾病和鼻塞的盛行率不斷增加，以及該領域對非侵入性治療解決方案的需求，外鼻擴張器的市場可能會成長。

市場動態：

司機

人們對打鼾和睡眠障礙的認知不斷提高

有幾個因素影響了全球外鼻擴張器市場的整體需求。隨著打鼾和睡眠障礙對健康的風險越來越為人所知，人們正在尋找在非侵入性睡眠時更好地呼吸的方法。外鼻擴張器的進步被認為是減少打鼾和促進呼吸的工具，有助於市場成長。

許多人尋求非侵入性方法來解決與前方呼吸有關的問題，例如鼻塞和呼吸困難。外鼻擴張器是簡單且非手術的選擇，可移動鼻孔開口區域以減少鼻呼吸困難。

此外，美國主要參與者推出新的意識計劃將推動該市場的成長。 2023 年 2 月，美國睡眠醫學會發起了「不僅僅是打鼾」活動，以提高人們對阻塞性睡眠呼吸中止症和打鼾的認知。該活動旨在提高全國對睡眠呼吸中止症的認知，並鼓勵未確診的患者為自己及其治療辯護。

此外，運動員和鍛鍊身體以提高成績的人經常使用鼻擴張器。這些條帶被認為可以促進氧氣攝入和通氣，從而增強耐力和整體表現。

一般來說，外鼻擴張器使用簡單，不需要任何特殊訓練或藥物治療。它們的吸引力歸因於它們的便利性，因為消費者無需專家指導即可實施它們。非處方外鼻擴張器在藥局、雜貨店和線上零售商處隨處可見。對於任何尋求緩解鼻塞和相關問題的人來說，它們是一個實用的選擇，因為它們易於使用。

限制

諸如設備成本高、擴張器缺乏可重複使用性、粘合劑刺激皮膚引起的不適、缺乏認知和採用、替代解決方案的競爭、產品選擇有限以及它們對某些類型的打鼾效果有限等因素預計將阻礙市場。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 人們對打鼾和睡眠障礙的認知不斷提高
      • 運動員鼻擴張的需求增加
      • 醫療保健技術進步
    • 限制
      • 設備成本高昂
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 未滿足的需求
  • PESTEL分析
  • 專利分析
  • SWOT分析

第 6 章：COVID-19 分析

第 7 章：按產品類型

第 8 章：黏性鼻擴張器*

  • 彈簧鼻擴張器
  • 鼻帶
  • 鼻夾

第 9 章：按申請

  • 鼻塞
  • 打鼾
  • 運動性鼻擴張
  • 睡眠呼吸中止症
  • 其他

第 10 章：依年齡層

  • 成年人
  • 兒科

第 11 章：按銷售管道

  • 醫院藥房
  • 運動及健身中心
  • 零售藥局
  • 網路藥局
  • 其他

第 12 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第13章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 14 章：公司簡介

  • GlaxoSmithKline Plc
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • SleepRight
  • Health Right Products LLC
  • Walmart Inc
  • Airware Labs
  • Walgreen Co
  • SHREYAAS HEALTH CARE PVT LTD
  • Nasilator
  • Rhinomed Limited
  • McKeon Products, Inc (LIST NOT EXHAUSTIVE)

第 15 章：附錄

簡介目錄
Product Code: MD1289

Market Overview

The Global External Nasal Dilators Market reached US$ 179.80 million in 2023 and is expected to reach US$ 273.22 million by 2031, growing at a CAGR of 5.5% during the forecast period 2024-2031.

External nasal dilators (ENDs) are adhesive bands containing a central elastic strip that reduce nasal resistance and inspiratory pressure by preventing the collapse of the lateral nasal vestibule. ENDs are applied horizontally to the skin of the nasal dorsum.

The external nasal dilator is a plastic or silicone device. It is 2 strips of adhesive with spring-like bands that expand the nasal passages by lifting and holding open the sides of the nose. This action decreases nasal airway resistance and allows improved airflow.

The market for external nasal dilators is likely to grow due to the increasing prevalence of snoring, sleep-related disorders & clogged noses among people as well as the demand for non-invasive treatment solutions in this area.

Market Dynamics: Drivers

Growing Awareness of Snoring and Sleep Disorders

Several factors contribute to the overall demand for the global external nasal dilator market. As the risks of snoring and sleep disorders to health become more widely known, people are looking for ways to breathe better while they sleep non-invasively. Advancements in external nasal dilators are advocated as tools to decrease snoring and facilitate respiration, contributing to market growth.

A lot of people look for non-invasive methods to deal with problems concerning breathing in ahead such as nasal congestion and restriction. External nasal dilators are simple and non-surgical options to move the area of the nostrils opening to reduce nasal breathing difficulties.

Moreover, major players in the U.S. introducing the new awareness program would propel this market growth. In February 2023, the American Academy of Sleep Medicine launched "More than a Snore" to raise awareness of obstructive sleep apnea and snoring. This campaign aims to raise national awareness of sleep apnea and encourage undiagnosed patients to advocate for themselves and their treatment.

In addition, nasal dilators are frequently used by athletes and those who exercise to improve their performance. These strips are thought to promote oxygen intake and ventilation, which could enhance endurance and general performance.

In general, external nasal dilators are simple to use and don't involve any special training or medication. Their appeal is attributed to their convenience since consumers can implement them without requiring expert guidance. The over-the-counter versions of external nasal dilators are widely accessible in pharmacies, grocery stores, and online retailers. They are a practical option for anyone looking for relief from nasal congestion and related problems because of their easy accessibility.

Restraints

Factors such as the high cost of the devices, lack of reusability of dilators, discomfort due to skin irritation from the adhesive, lack of awareness and adoption, competition from alternative solutions, limited product options, and their limited effectiveness for certain types of snoring these are expected to hamper the market.

Segment Analysis

The global external nasal dilator market is segmented based on product type, application, age group, sales channel, and region.

The nasal congestion segment accounted for approximately 67.4% of the global external nasal dilator market share

The nasal congestion segment is expected to hold the largest market share over the forecast period. Nasal congestion occurs when the nasal passages and the tissues around them as well as blood vessels swell due to excessive fluids. The blocked nose condition comes from this irritation that also gives one a sense of complexation or closure in the nostrils. For infants who cannot be fed due to the congestion or children whose sleep is disturbed by it, a child's stuffy nose could be very distressing.

The more extended their nasal cavity is, the folks with blocked noses get immensely alleviated by that alone. For instance, Bausch Health Companies Inc. revealed on May 2023 that RYALTRIS, a new medication combining mometasone furoate nasal spray with olopatadine hydrochloride can now be found throughout Canada.

Health Canada has authorized RYALTRIS for symptomatic medical management of adults, adolescents, and children six years of age and above having mild to severe spring allergic sinusitis (SAR) with related vision problems. The need for external nasal dilators is rising along with the frequency of nasal congestion, which is fueling the expansion of the external nasal dilator market globally throughout the forecast period.

Geographical Analysis

North America accounted for approximately 41.3% of the global external nasal dilator market share

North America region is expected to hold the largest market share over the forecast period due to the high frequency of long-term sinusitis, reputable suppliers, and rising knowledge of the advantages of external nasal dilatation over alternative techniques.

In the United States, obstructive sleep apnea will affect around 30 million persons by 2023. Roughly 80% of these cases go undetected, resulting in health care costs, decreased productivity at work, and workplace and auto accidents costing the United States more than $149 billion yearly.

Sleep problems can reduce productivity at work and have major health repercussions. According to CDC projections from August 2023, nearly one-third of adult Americans sleep fewer hours than recommended and sleep disorders represent a major public health emergency.

Additionally, the cost of healthcare has increased as a result of the growing prevalence of chronic diseases in North America. Due to the high prevalence of snoring, chronic sinusitis, and rhinosinusitis, North America is expected to have the highest revenue share in the global external nasal dilator market, which in turn drives the regional market during the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global external nasal dilator market. The pandemic affected the manufacture and delivery of a variety of commodities, including medical equipment like nasal strips and external nasal dilators, by upsetting global supply networks.

It's possible that lockdowns, travel restrictions, and labor scarcity contributed to supply and manufacturing delays. There may have been changes in consumer behavior during the epidemic, such as a greater emphasis on wellness and health items. It's possible that some people have become more interested in devices like external nasal dilators to breathe easier and sleep better.

Market Segmentation

By Product Type

  • Adhesive Nasal Dilator
  • Spring Nasal Dilator
  • Nasal Strips
  • Nasal Clips

By Application

  • Nasal Congestion
  • Snoring
  • Athletic Nasal Dilation
  • Sleep Apnea
  • Others

By Age Group

  • Adults
  • Pediatrics

By Sales Channel

  • End-User
  • Hospital Pharmacies
  • Sports and Fitness Centers
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the external nasal dilator market include GlaxoSmithKline Plc, SleepRight, Health Right Products LLC, Walmart Inc, Airware Labs, Walgreen Co, SHREYAAS HEALTH CARE PVT LTD, Nasilator, Rhinomed Limited, McKeon Products, Inc and among others.

Key Developments

  • In April 2024, Intake Breathing, a leading provider of innovative breathing solutions, announced the launch of its groundbreaking Intake Breathing nasal dilator. This two-part nasal dilator system is designed to dramatically open the nasal passages, allowing for improved breathing, deeper sleep, and enhanced overall well-being.
  • In February 2023, Johnson & Johnson MedTech introduced the RELIEVA TRACT nasal dilation system features a novel mechanism of action that empowers you to create space for your nasal procedures
  • In October 2021, Foundation Consumer Healthcare (FCH) announced a partnership with two-time NASCAR champion, Kyle Busch. Together, Busch and FCH are working to increase awareness of the potential benefits and uses of Breathe Right nasal strips.

Why Purchase the Report?

  • To visualize the global external nasal dilator market segmentation based on product type, application, age group, sales channel, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of global external nasal dilator market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in excel consisting of key products of all the major players.

The global external nasal dilator market report would provide approximately 70 tables, 66 figures, and 182 Pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by Age Group
  • 3.4. Snippet by Sales Channel
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Awareness of Snoring and Sleep Disorders
      • 4.1.1.2. Increased Demand from Athletes Nasal Dilation
      • 4.1.1.3. Technological Advancements in Healthcare
    • 4.1.2. Restraints
      • 4.1.2.1. The High Cost of Devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. PESTEL Analysis
  • 5.7. Patent Analysis
  • 5.8. SWOT Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • Adhesive Nasal Dilator*
  • 7.1. Introduction
  • 7.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Spring Nasal Dilator
  • 7.4. Nasal Strips
  • 7.5. Nasal Clips

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Nasal Congestion*
    • 9.2.1. Introduction
  • 9.3. Snoring
  • 9.4. Athletic Nasal Dilation
  • 9.5. Sleep Apnea
  • 9.6. Others

10. By Age Group

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 10.1.2. Market Attractiveness Index, By Age Group
  • 10.2. Adults*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Pediatrics

11. By Sales Channel

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 11.1.2. Market Attractiveness Index, By Sales Channel
  • 11.2. Hospitals Pharmacies*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Sports and Fitness Centers
  • 11.4. Retail Pharmacies
  • 11.5. Online Pharmacies
  • 11.6. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.7.1. U.S.
      • 12.2.7.2. Canada
      • 12.2.7.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.7.1. Germany
      • 12.3.7.2. UK
      • 12.3.7.3. France
      • 12.3.7.4. Italy
      • 12.3.7.5. Spain
      • 12.3.7.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.7.1. Brazil
      • 12.4.7.2. Argentina
      • 12.4.7.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.7.1. China
      • 12.5.7.2. India
      • 12.5.7.3. Japan
      • 12.5.7.4. South Korea
      • 12.5.7.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. GlaxoSmithKline Plc *
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio & Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. SleepRight
  • 14.3. Health Right Products LLC
  • 14.4. Walmart Inc
  • 14.5. Airware Labs
  • 14.6. Walgreen Co
  • 14.7. SHREYAAS HEALTH CARE PVT LTD
  • 14.8. Nasilator
  • 14.9. Rhinomed Limited
  • 14.10. McKeon Products, Inc (LIST NOT EXHAUSTIVE)

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us